New Export Rules Announced for Doxycycline 100 mg Tablets by Center

On April 24, 2025, the fixation of a Standard Input Output Norm for Doxycycline 100 mg dispersible tablets under the chemical and Allied products category comes under product code ‘A’. This public notice has been issued by the Directorate General of Foreign Trade, to streamline and promote pharmaceutical exports.

The new SION ‘A-3685’ specifies that the number of Doxycycline 100 mg are allowed to export and Doxycycline Monohydrate U.S.P/B. P is 106.13 mg are allowed to import.

Doxycycline is a broad-spectrum antibiotic that treats numerous bacterial infections which is effective at fighting against bacteria like Moraxella catarrhalis, Brucella melitensis, Chlamydia pneumoniae, and Mycoplasma pneumonia. It can also be used to treat pimples and abscesses that are caused by rosacea.

This activity is expected to ease the procedural aspects of exports, particularly for Indian pharmaceutical companies specializing in antibiotic formulations, and when they promote greater competitiveness in international markets.

It does provide more clarity and facilitation to pharmaceutical manufacturers and exporters by regulating the material requirement for producing the widely used antibiotic in the dispersible form.  This will improve India as a major supplier of essential medicines and create the global demand for affordable, high-quality antibiotics, especially in developing and under-developed countries.